A brain lesion with tumor cells expressing cytokeratin, chromogranin, and synaptophysin most likely metastasized from which primary cancer?

Prepare for the NBME Form 16 with our comprehensive quiz. Tackle multiple choice questions with insights and explanations. Enhance your confidence and accuracy for the exam!

Multiple Choice

A brain lesion with tumor cells expressing cytokeratin, chromogranin, and synaptophysin most likely metastasized from which primary cancer?

Explanation:
Immunohistochemical profiling helps identify where a metastatic brain tumor originated by matching marker patterns. Cytokeratin signals epithelial origin, while chromogranin and synaptophysin indicate neuroendocrine differentiation. A brain lesion that coexpresses epithelial markers with neuroendocrine markers points to a neuroendocrine tumor of a distant organ, most commonly small cell carcinoma of the lung, as the primary source. Glioblastoma multiforme is a primary brain tumor and would typically show GFAP positivity rather than neuroendocrine markers. Melanoma would usually express S-100 and related melanoma markers rather than chromogranin/synaptophysin, and renal cell carcinoma often lacks neuroendocrine markers. Thus, the pattern described best fits metastasis from small cell lung cancer.

Immunohistochemical profiling helps identify where a metastatic brain tumor originated by matching marker patterns. Cytokeratin signals epithelial origin, while chromogranin and synaptophysin indicate neuroendocrine differentiation. A brain lesion that coexpresses epithelial markers with neuroendocrine markers points to a neuroendocrine tumor of a distant organ, most commonly small cell carcinoma of the lung, as the primary source. Glioblastoma multiforme is a primary brain tumor and would typically show GFAP positivity rather than neuroendocrine markers. Melanoma would usually express S-100 and related melanoma markers rather than chromogranin/synaptophysin, and renal cell carcinoma often lacks neuroendocrine markers. Thus, the pattern described best fits metastasis from small cell lung cancer.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy